Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy

The 2012 Hormone Therapy Position Statement of The North American Menopause Society

(2016)   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Sexual Activity and Satisfaction in Healthy Community-dwelling Older Women

(2011) Susan E. Trompeter et al.   AMERICAN JOURNAL OF MEDICINE

Progress and Prospects in Treating Postmenopausal Vaginal Atrophy

(2010) R C Winneker et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Continuing Medical Education: Vulvovaginal Atrophy: Current and Future Therapies (CME)

(2010) Comfort Ibe et al.   Journal of Sexual Medicine

Recognizing and Treating Urogenital Atrophy in Postmenopausal Women

(2010) Irwin Goldstein   JOURNAL OF WOMENS HEALTH

Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview

(2009) O. Al-Baghdadi et al.   CLIMACTERIC

Urogenital atrophy

(2009) J. Calleja-Agius et al.   CLIMACTERIC

Continuing Medical Education: The Use of Estrogen Therapy in Women's Sexual Functioning (CME)

(2009) Rossella E. Nappi et al.   Journal of Sexual Medicine

Prevalence and Impact of Vaginal Symptoms among Postmenopausal Women

(2009) Nanette Santoro et al.   Journal of Sexual Medicine

Vulvovaginal Atrophy

(2009) Maire B. Mac Bride et al.   MAYO CLINIC PROCEEDINGS

Pharmacologic Effects of Ospemifene in Rhesus Macaques: A Pilot Study

(2008) Gregory T. Wurz et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY